Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)
Status:
Completed
Trial end date:
2017-01-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate two different treatment strategies in patients
admitted to hospital with Community Acquired Pneumonia. The investigators hypothesize
treatment according to both procalcitonin (PCT) and C-reactive protein (CRP) will be
effective in reducing the length of antibiotic treatment.